Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
Ansab Akhtar(Louisiana State University Health Sciences Center New Orleans), Arvind Negi(Aalto University), Devendra Kumar(Dehradun Institute of Technology University), Shubham Dwivedi(University of Petroleum and Energy Studies), Shraddha Manish Gupta, Mohd. Farooq Shaikh(University of Mumbai)
Cited by 77
Related Papers
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
|European Journal of Pharmacology|2019|175
Alcohol Use Disorder, Neurodegeneration, Alzheimer’s and Parkinson’s Disease: Interplay Between Oxidative Stress, Neuroimmune Response and Excitotoxicity
|Frontiers in Cellular Neuroscience|2020|160
Alcohol, Aggression, and Violence: From Public Health to Neuroscience
|Frontiers in Psychology|2021|144